Personally this paragraph here sums up why I'm holding. Plenty of upside on the horizon, 'should' be a good string of announcements and positive contract wins assuming they manage to follow through. Hopefully we see a few more long-termers take a look. Definitely need a 12mth+ horizon on this..!
“Executive Chairman of Uscom, Associate Professor Rob Phillips said, “This contract facilitates sales into over 1000 UK Hospital trusts and into GP practices, and is the foundation for the European marketing of the BP+. The BP+ has TGA (Australian), CE (European) and FDA (USA) approval, and we are mid CFDA (China) application now. BP+ is currently being prepared for global release to market, and we are negotiating world wide with partners in Pharma and clinical markets to deliver this sector leading technology rapidly and profitably, particularly in the USA, where we have both technology and price advantages over our competitors.”
GLTA, DYOR, IMO etc
Add to My Watchlist
What is My Watchlist?
